Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - LONG-TERM DEBT
Long-term Debt TVTX - Travere Therapeutics, Inc.
400 M
LAST VALUE
24.48%
2 YEAR CAGR
15.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR